Related Experiment Video
Updated: Jun 6, 2026

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS)
Published on: March 14, 2013
High-throughput metabolic toxicity screening using magnetic biocolloid reactors and LC-MS/MS
Linlin Zhao1, John B Schenkman, James F Rusling
1Department of Chemistry, University of Connecticut, Storrs, Connecticut 06269-3060, United States.
A new, affordable high-throughput genotoxicity screening method uses magnetic particles and advanced LC-MS/MS to detect DNA adducts. This approach aids in identifying potential chemical mutagens and complements toxicity testing.
Area of Science:
- Biochemistry
- Toxicology
- Analytical Chemistry
Background:
- Genotoxicity screening is crucial for chemical safety assessment.
- Existing methods can be costly and time-consuming.
- Metabolic activation is key to understanding chemical-induced DNA damage.
Purpose of the Study:
- To develop an inexpensive, high-throughput genotoxicity screening method.
- To utilize magnetic particles as biocolloid reactors for chemical bioactivation and DNA adduct formation.
- To couple this method with liquid chromatography-mass spectrometry for sensitive adduct detection.
Main Methods:
- Magnetic particles coated with cytosol/microsome/DNA films were used in a 96-well plate format.
- Enzymes within the films bioactivated chemicals, forming reactive metabolites.
- Metabolites covalently bound to DNA, forming nucleobase adducts, which were analyzed by LC-MS/MS.
Main Results:
- The method successfully identified major DNA adducts from ethylene dibromide, N-acetyl-2-aminofluorene, and styrene.
- DNA adduct formation rates correlated well with the rodent genotoxicity metric TD(50).
- Magnetic particles facilitated rapid sample preparation and analysis.
Conclusions:
- This novel method offers a cost-effective and high-throughput approach for genotoxicity screening.
- It provides valuable chemical structure information complementary to traditional toxicity bioassays.
- The technique shows promise for early-stage chemical safety evaluation and drug development.
More Related Videos
11:00Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry (UPLC-HRMS)
Published on: May 20, 2013
07:55Integrated Cell Manipulation Platform Coupled with the Single-probe for Mass Spectrometry Analysis of Drugs and Metabolites in Single Suspension Cells
Published on: June 21, 2019